Physician
Gonjon, Cheng
Gonjon, Cheng was paid $53K by Medicaid between Jan 2018 and Nov 2023, across 91 billing codes. Its largest line is G0447, Face-to-face behavioral counseling for obesity, 15 minutes — 21% of everything it billed.
33Billing provider infoGONJON, CHENG
NEW YORK, NY 10040
NEW YORK, NY 10040
33aNPI1851364806assigned 02/09/2006
33bProvider typeEmergency Medicine Physician
28Total paid$53K
24GClaims57,535
24DCodes billed91
24AFirst – last monthJan 2018 – Nov 2023
Compared with peers
Next to other Emergency Medicine Physician providers in New York
Rank by total paid#194 of 2,113
Median peer was paid$5K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,711 | $19K | |
| 2019 | 12,133 | $19K | |
| 2020 | 29,953 | $7K | |
| 2021 | 9,700 | $8K | |
| 2022 | 1,638 | $298.48 | |
| 2023 | 400 | $5.16 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 21% | 1,329 | 1,282 | $11K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 599 | 586 | $11K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 11% | 1,357 | 1,132 | $6K |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 11% | 554 | 435 | $6K |
| G0444 | Annual depression screening, 5 to 15 minutes | 8.7% | 868 | 854 | $5K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 6.1% | 651 | 646 | $3K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 5.4% | 468 | 459 | $3K |
| 99408 | 4.3% | 697 | 663 | $2K | |
| 99442 | 4.1% | 991 | 939 | $2K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 2.9% | 1,749 | 1,349 | $2K |
| 81000 | 2.8% | 1,010 | 980 | $1K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 253 | 191 | $300.20 |
79 more codes
| 3079F | <1% | 110 | $265.00 | |
| 3074F | <1% | 109 | $255.00 | |
| 97802 | <1% | 1,305 | $82.50 | |
| 1126F | <1% | 58 | $35.00 | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 1,017 | $10.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 857 | $8.55 |
| 82962 | <1% | 1,143 | $6.24 | |
| 96127 | <1% | 975 | $5.94 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 192 | $5.16 |
| 82948 | <1% | 32 | $4.79 | |
| 96160 | <1% | 695 | $2.86 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 930 | $2.67 |
| 84442 | <1% | 662 | $2.14 | |
| 82043 | <1% | 904 | $2.05 | |
| 82040 | <1% | 634 | $1.53 | |
| 84479 | <1% | 570 | $1.24 | |
| 86592 | <1% | 587 | $0.85 | |
| 86703 | <1% | 528 | $0.78 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 558 | $0.48 |
| 81003 | <1% | 735 | $0.41 | |
| 80053 | Comprehensive metabolic panel | <1% | 712 | $0.16 |
| 82565 | <1% | 634 | $0.08 | |
| 84520 | <1% | 668 | $0.04 | |
| 83719 | <1% | 685 | $0.02 | |
| 80061 | Lipid panel | <1% | 844 | $0.02 |
| 80051 | <1% | 793 | $0.01 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 611 | $0.00 |
| G9912 | Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy | 0% | 1,373 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 1,079 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 804 | $0.00 |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 1,937 | $0.00 |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 0% | 1,090 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 107 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 758 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 0% | 46 | $0.00 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 166 | $0.00 |
| 86706 | 0% | 45 | $0.00 | |
| 80069 | 0% | 152 | $0.00 | |
| 99429 | 0% | 515 | $0.00 | |
| 3008F | 0% | 56 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 44 | $0.00 |
| 84132 | 0% | 154 | $0.00 | |
| 82575 | 0% | 149 | $0.00 | |
| 3011F | 0% | 214 | $0.00 | |
| 3014F | 0% | 62 | $0.00 | |
| 3017F | 0% | 76 | $0.00 | |
| 4210F | 0% | 44 | $0.00 | |
| 1036F | 0% | 125 | $0.00 | |
| 86803 | 0% | 49 | $0.00 | |
| 84480 | 0% | 152 | $0.00 | |
| 4010F | 0% | 44 | $0.00 | |
| 82270 | 0% | 13 | $0.00 | |
| 1000F | 0% | 134 | $0.00 | |
| 86705 | 0% | 45 | $0.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 1,286 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 264 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,158 | $0.00 |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | 0% | 245 | $0.00 |
| G9383 | Patient received screening for hcv infection within the 12 month reporting period | 0% | 366 | $0.00 |
| 82947 | 0% | 61 | $0.00 | |
| 86480 | 0% | 13 | $0.00 | |
| 99080 | 0% | 13,130 | $0.00 | |
| 83721 | 0% | 126 | $0.00 | |
| 3016F | 0% | 102 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 744 | $0.00 |
| 99401 | 0% | 325 | $0.00 | |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 223 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 309 | $0.00 |
| 0403T | 0% | 56 | $0.00 | |
| 86709 | 0% | 47 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 34 | $0.00 |
| 2028F | 0% | 33 | $0.00 | |
| 1033F | 0% | 123 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 77 | $0.00 |
| 3725F | 0% | 105 | $0.00 | |
| 0521F | 0% | 132 | $0.00 | |
| 3015F | 0% | 44 | $0.00 | |
| 82272 | 0% | 13 | $0.00 | |
| 82274 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.